Apotexsp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-12-14
Share capital
50,000.00 PLN
Registered address
Sienkiewicza 12, 48-385 Otmuchów, Poland
Electronic delivery address
AE:PL-52877-22210-RAUAH-27

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 35 days early. 1 of 6 audited by a statutory auditor.

  • 202511/06/2026
  • 202428/03/2025
  • 202328/06/2024
  • 202229/06/2023
  • 202129/06/2022
  • 202029/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 2.05mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 27.74kMedianUSD 20.66kAverageUSD 86.62k
Operating costs
This companyUSD 1.97mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 1.35mMedianUSD 544.32kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Apotex has been an NFZ healthcare provider since 2023. In 2026 it is performing 2 contracts with a total value of USD 21.90k. All its contracts were worth USD 37.49k in total.

NFZ contract value by year (in k USD)

Type of careNFZ branchContractsValue in 2026
Other services provided in pharmaciesopolskie2USD 21.90k

Authorized Representatives

Marzenna Orłowska Plizga
Piotr Plizga – Attorney-in-fact (sole)

Manner of representation

President of the Management Board independently.

Ownership

OwnerSharesShare valueStake
Jan Kazimierz Czabanowskiage 79
36$4,862.2436%
Marzenna Maria Orłowska Plizgaage 59
64$8,643.9864%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2002-01-07.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

6 public aid cases recorded, with a total value of $65,129.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$1
De minimis aid (in accordance with Commission Regulation 2023/2831)
$1,391
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,899

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
MybestpharmS.A.
Novopharm - Millersp. j.
Pikadasp. z o.o.
Vitasp. z o.o.
Gold Lionsp. z o.o.
Grupa Aptekarska Kujałowiczsp. j.
Herbarium Świętego Franciszkasp. z o.o.
Eurekasp. z o.o.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.

Change history

DateEvent
2006-02-10Share capital increase
2004-09-17Address change
2001-12-14Entered in the register

FAQ

Last updated: 2026-08-20